P-263Survival analysis of a multicentre, randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC)Antonio Avallone,Guglielmo Nasti,Gerardo Rosati,Chiara Carlomagno,Carmela Romano,Domenico Bilancia,A. De Stefano,Lucrezia Silvestro,Alessandro Ottaiano,Antonino Cassata,Franco Bianco,Francesco Izzo,Paolo Delrio, E De Gennaro,Rossana Casaretti,Salvatore Tafuto,V Albino,U Pace,Secondo Lastoria,Ciro Gallo,Alfredo Budillon,Maria Carmela PiccirilloANNALS OF ONCOLOGY(2018)引用 0|浏览106暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要